TAG:
molecular testing
New Lab Company to Buy Westcliff, Health Line
CEO SUMMARY: In Southern California, no one’s talking for the record, but everyone’s talking about the impending acquisition of Westcliff Medical Laboratories and Health Line Clinical Laboratories by a new laboratory company. The deals are expected to close by the end of this month. T…
“December 5, 2005 Intelligence: Late Breaking Lab News”
On November 9, Luminex Corporation was awarded the “2005 Clinical Diagnostics Technology of the Year” Award from Frost & Sullivan. The award recognizes “clinical diagnostics technology that shows the potential to become an industry standard, achieve a high …
Top Ten Clinical Molecular Companies
…
Picking Winners and Losers For the Molecular Test Menu
CEO SUMMARY: In the 15 years it has operated a molecular diagnostics testing program, Beaumont Reference Laboratory (BRL) has learned important lessons on how to evaluate which specific molecular assays are ready for clinical introduction. It has also learned effective ways to anticipate …
For Quest and LabCorp, The Story is “Molecular”
CEO SUMMARY: Wall Street likes the potential of molecular diagnostics to infuse new revenues and operating profits into the laboratory industry. That is one reason Quest Diagnostics Incorporated and Laboratory Corporation of America are assertively seeking exclusive access to new molecula…
Molecular Diagnostics: How Beaumont Built A Successful Program
CEO SUMMARY: It was about 15 years ago when William Beaumont Hospital and Beaumont Reference Laboratories first began offering molecular diagnostic testing services to clinicians. This successful effort came about because of effective strategic planning, use of consulting expertise at key…
Lab Innovators Point Way At Executive War College
CEO SUMMARY: Now in its tenth year, this Executive War College attracted a record crowd, including laboratory leaders from Europe, Africa, South America, and Asia. The unexpected finding was that, along with the growing acceptance of Lean, Six Sigma and other quality management systems by…
For Molecular Tests, Evaluate All Factors
CEO SUMMARY: When this hospital lab adopted molecular screening tests for Chlamydia trachomatis and Neisseria gonorrhoaea, physicians soon noticed a change in the rate of false positives. In researching the performance of the molecular assays compared to cultures, pathologists at this lab…
LIS Market Evolving To Serve New Needs
CEO SUMMARY: Ongoing reimbursement declines, coupled with other key factors, are pushing labs to seek new capabilities for their laboratory information systems (LIS). Another influence is the growth of molecular diagnostic programs in hospital labs. Molecular testing places unique demands…
Leonard Joins AEL’s Board, Cenetron Is Newest Acquisition
There were two big announcements at American Esoteric Laboratories, Inc. (AEL) during the past few weeks. First came news on July 20 that Larry L. Leonard was now on the Board of Directors at AEL. Leonard had been part of the senior executive team at Laboratory Corporation o…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.